B D Ross|J Espinal|P Silva

Showing results (371-380 of 2,744) with videos related to

Pageof 275

Sort By:

Current Drug Targets. CNS and Neurological Disorders|August 17, 2005

The putative neuroprotective role of neuropeptide Y in the central nervous systemAna P Silva, Sara Xapelli, Eric Grouzmann, et al.

Polymers|February 28, 2023

Effect of Carbon Nanofibers on the Viscoelastic Response of Epoxy ResinsPaulo Santos, Abílio P Silva, Paulo N B Reis

ARP Rheumatology|September 7, 2024

Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab - a case-based reviewSusana P Silva, Gisela Eugénio, Miguel Pinto, et al.

Cureus|April 11, 2025

Unshrinking the Lung: Successful Improvement of Shrinking Lung Syndrome in Systemic Lupus Erythematosus Through Non-invasive Ventilation and Respiratory RehabilitationPedro Fernandes, Ana Luis, João P Silva, et al.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 23, 2018

Preclinical and clinical development of palbociclib and future perspectivesE Martínez de Dueñas, J Gavila-Gregori, S Olmos-Antón, et al.

Gene Therapy|September 16, 2005

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefitK C Lee, D A Hamstra, S Bullarayasamudram, et al.

Magma (New York, N.Y.)|December 8, 2004

Diffusion imaging for evaluation of tumor therapies in preclinical animal modelsB A Moffat, D E Hall, J Stojanovska, et al.

NMR in Biomedicine|July 28, 1999

In vivo magnetic resonance spectroscopy of human fetal neural transplantsB D Ross, T Q Hoang, S Blüml, et al.

Journal of Computer Assisted Tomography|January 1, 1987

Clinical magnetic susceptibility mapping of the brainI R Young, S Khenia, D G Thomas, et al.

Gene Therapy|June 29, 2000

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategyL D Stegman, A Rehemtulla, D A Hamstra, et al.

Pageof 275

Showing results (371-380 of 2,744) with videos related to

Sort By:

Pageof 275

Current Drug Targets. CNS and Neurological Disorders|August 17, 2005

The putative neuroprotective role of neuropeptide Y in the central nervous systemAna P Silva, Sara Xapelli, Eric Grouzmann, et al.

Polymers|February 28, 2023

Effect of Carbon Nanofibers on the Viscoelastic Response of Epoxy ResinsPaulo Santos, Abílio P Silva, Paulo N B Reis

ARP Rheumatology|September 7, 2024

Clinical and persistent remission in anti-HMGCR immune-mediated necrotizing myopathy to a single cycle of rituximab - a case-based reviewSusana P Silva, Gisela Eugénio, Miguel Pinto, et al.

Cureus|April 11, 2025

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 23, 2018

Preclinical and clinical development of palbociclib and future perspectivesE Martínez de Dueñas, J Gavila-Gregori, S Olmos-Antón, et al.

Gene Therapy|September 16, 2005

Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefitK C Lee, D A Hamstra, S Bullarayasamudram, et al.

Magma (New York, N.Y.)|December 8, 2004

Diffusion imaging for evaluation of tumor therapies in preclinical animal modelsB A Moffat, D E Hall, J Stojanovska, et al.

NMR in Biomedicine|July 28, 1999

In vivo magnetic resonance spectroscopy of human fetal neural transplantsB D Ross, T Q Hoang, S Blüml, et al.

Journal of Computer Assisted Tomography|January 1, 1987

Clinical magnetic susceptibility mapping of the brainI R Young, S Khenia, D G Thomas, et al.

Gene Therapy|June 29, 2000

Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategyL D Stegman, A Rehemtulla, D A Hamstra, et al.

Pageof 275